Drug interactions between Epogen and lisinopril
Results for the following 2 drugs: |
|
|---|---|
| Epogen (epoetin alfa) | |
| lisinopril | |
Interactions between your selected drugs
epoetin alfa ⇔ lisinopril
Applies to: Epogen (epoetin alfa) and lisinopril
Angiotensin-converting enzyme (ACE) inhibitors may interfere with the effects of both endogenous and exogenous erythropoietin, although data are conflicting with respect to the latter. A retrospective investigation of 43 dialysis patients treated with human recombinant erythropoietin for an average of ten months found that the group also receiving captopril had lower hemoglobin and hematocrit levels than the control group when given the same dosage of erythropoietin, and the difference was statistically significant. However, another retrospective investigation found no significant differences in the mean hematocrit level and erythropoietin dosage in 14 stable hemodialysis patients for up to 16 weeks before and 16 weeks after initiation of ACE inhibitor therapy. Previous studies have suggested that ACE inhibitors may interfere with hematopoiesis by decreasing the synthesis of endogenous erythropoietin or decreasing bone marrow production of red blood cells, but an actual pharmacokinetic or pharmacodynamic interaction with erythropoietin has not been reported. Until further data are available, it may be appropriate to monitor patients for potentially diminished hematopoietic response to recombinant erythropoietin therapy following the addition of an ACE inhibitor.
See also...
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. Multum's drug information does not endorse drugs, diagnose patients, or recommend therapy. Multum's drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2009 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
